Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' MAGRATH I' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 54 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Magrath, I
      Editorial comment on detection of Epstein-Barr virus DNA in peripheral blood of paediatric patients with Hodgkin's disease by real-time polymerase chain reaction by Wagner and colleagues

      EUROPEAN JOURNAL OF CANCER
    2. Gurbuxani, S; Arya, LS; Raina, V; Sazawal, S; Khattar, A; Magrath, I; Marie, JP; Bhargava, M
      Significance of MDR1, MRP1, GST pi and GST mu mRNA expression in acute lymphoblastic leukemia in Indian patients

      CANCER LETTERS
    3. Sazawal, S; Gurbuxani, S; Bhatia, K; Khattar, A; Raina, V; Arya, LS; Vats, T; Magrath, I; Bhargava, M
      Incidence, clinical characteristics and early treatment outcome in Indian patients of childhood acute lymphoblastic leukemia with ALL-1 gene rearrangement

      LEUKEMIA RESEARCH
    4. Rao, CR; Franklin, J; Lalitha, N; Bhatia, K; O'Conor, G; Magrath, I
      Frequency of Epstein-Barr virus (EBV) association and p53 expression in childhood and adult Hodgkin's disease in India

      INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY
    5. Rao, CR; Gutierrez, MI; Bhatia, K; Fend, F; Franklin, J; Appaji, L; Gallo, G; O'Conor, G; Lalitha, N; Magrath, I
      Association of Burkitt's lymphoma with the Epstein-Barr virus in two developing countries

      LEUKEMIA & LYMPHOMA
    6. Gutierrez, MI; Kingma, DW; Sorbara, L; Tran, M; Raffeld, M; Jaffe, ES; Magrath, I; Bhatia, K
      Association of EBV strains, defined by multiple loci analyses, in non-Hodgkin lymphomas and reactive tissues from HIV positive and HIV negative patients

      LEUKEMIA & LYMPHOMA
    7. Nerurkar, AY; Vijayan, P; Srinivas, V; Soman, CS; Dinshaw, KA; Advani, SH; Magrath, I; Bhatia, K; Naresh, KN
      Discrepancies in Epstein-Barr virus association at presentation and relapse of classical Hodgkin's disease: Impact on pathogenesis

      ANNALS OF ONCOLOGY
    8. Naresh, KN; Johnson, J; Srinivas, V; Soman, CS; Saikia, T; Advani, SH; Badwe, RA; Dinshaw, KA; Muckaden, M; Magrath, I; Bhatia, K
      Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells

      ANNALS OF ONCOLOGY
    9. Sazawal, S; Bhatia, K; Gurbuxani, S; Arya, LS; Raina, V; Khattar, A; Vats, T; Magrath, I; Bhargava, M
      Pattern of immunoglobulin (Ig) and T-cell receptor (TCR) gene rearrangements in childhood acute lymphoblastic leukemia in India

      LEUKEMIA RESEARCH
    10. Gutierrez, MI; Hamdy, N; Bhatia, K; Bornkamm, G; Lenoir, G; Epelman, S; Magrath, I
      Geographic variation in t(8;14) chromosomal breakpoint locations and EBV association in Burkitt's lymphoma

      INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY
    11. Sikora, K; Advani, S; Koroltchouk, V; Magrath, I; Levy, L; Pinedo, H; Schwartsmann, G; Tattersall, M; Yan, S
      Essential drugs for cancer therapy: A World Health Organization consultation

      ANNALS OF ONCOLOGY
    12. Advani, S; Pal, S; Venzon, D; Adde, M; Kurkure, PK; Nair, CN; Sirohi, B; Banavali, SD; Hawaldar, R; Kolhatkar, BB; Vats, T; Magrath, I
      Acute lymphoblastic leukemia in India: An analysis of prognostic factors using a single treatment regimen

      ANNALS OF ONCOLOGY
    13. Bhatia, K; Magrath, I
      EBNA-1 sequences in endemic and sporadic Burkitt's lymphoma

      JOURNAL OF VIROLOGY
    14. Gutierrez, MI; Cherney, B; Hussain, A; Mostowski, H; Tosato, G; Magrath, I; Bhatia, K
      Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis

      CANCER RESEARCH
    15. Magrath, I; Bhatia, K
      Breast cancer: a new Epstein-Barr virus-associated disease?

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    16. Inamdar, N; Kumar, SA; Banavali, SD; Advani, S; Magrath, I; Bhatia, K
      Comparative incidence of the rearrangements of TEL/AML1 and ALL1 genes in pediatric precursor B acute lymphoblastic leukemias in India

      INTERNATIONAL JOURNAL OF ONCOLOGY
    17. ADDE M; SHAD A; VENZON D; ARNDT C; GOOTENBERG J; NEELY J; NIEDER M; OWEN W; SEIBEL N; WILSON W; HORAK ID; MAGRATH I
      ADDITIONAL CHEMOTHERAPY AGENTS IMPROVE TREATMENT OUTCOME FOR CHILDRENAND ADULTS WITH ADVANCED B-CELL LYMPHOMAS

      Seminars in oncology
    18. SHAD A; MUELLER B; ADDE M; AVILA N; SLEASMAN J; PIZZO P; MAGRATH I
      RESULTS OF A TREATMENT PROTOCOL FOR CHILDREN WITH HIV AND NON-HODGKINS-LYMPHOMAS (NHLS)

      Journal of acquired immune deficiency syndromes and human retrovirology
    19. VENKATESH H; MEZACORIA C; LOPEZCORELLA E; RIDAURASANZ C; OCONOR G; LUNA RR; BHATIA K; MAGRATH I
      EXPRESSION OF P53 IN PEDIATRIC LYMPHOMAS FROM MEXICO - RELATION TO HISTOLOGY AND IMMUNOPHENOTYPE

      International journal of oncology
    20. ADVANI S; PAI S; ADDE M; VAIDYA S; VATS T; NARESH K; KURKURE PA; NAIR CN; VENZON D; MAGRATH I
      PRELIMINARY-REPORT OF AN INTENSIFIED, SHORT-DURATION CHEMOTHERAPY PROTOCOL FOR THE TREATMENT OF PEDIATRIC NON-HODGKINS-LYMPHOMA IN INDIA

      Annals of oncology
    21. GUTIERREZ MI; BHATIA K; CHERNEY B; CAPELLO D; GAIDANO G; MAGRATH I
      INTRACLONAL MOLECULAR HETEROGENEITY SUGGESTS A HIERARCHY OF PATHOGENETIC EVENTS IN BURKITTS-LYMPHOMA

      Annals of oncology
    22. SHAD A; MAGRATH I
      NON-HODGKINS-LYMPHOMA

      The Pediatric clinics of North America
    23. MAGRATH I
      LIMITING THERAPY FOR LIMITED CHILDHOOD NON-HODGINS-LYMPHOMA

      The New England journal of medicine
    24. GUTIERREZ MI; CHERNEY B; HUSSAIN A; MAGRATH I; BHATIA K
      EXPRESSION OF DEATH INDUCING GENES AND THE ACTIVATION OF DEATH INDUCING PATHWAY IN BURKITTS-LYMPHOMA

      Blood
    25. GUTIERREZ MI; CAPELLO D; CHERNEY B; GAIDANO G; MAGRATH I; BHATIA K
      INTRACLONAL MOLECULAR HETEROGENEITY SUGGESTS A HIERARCHY OF PATHOGENETIC EVENTS IN BURKITTS-LYMPHOMA

      Blood
    26. SAZAWAL S; BHATIA K; GURBUXANI S; ARYA LS; RAINA V; VATS T; MAGRATH I; BHARGAVA M
      SIGNIFICANCE OF IMMUNOGLOBULIN (IG) AND T-CELL RECEPTOR (TCR) GENE REARRANGEMENTS IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) IN INDIA

      Blood
    27. MAGRATH I; ADDE M; SHAD A; VENZON D; SEIBEL N; NEELEY J; GOOTENBERG J; ARNDT C; NIEDER M; OWEN W; WILSON W; HORAK I
      RELATIVE EFFICACY OF G AND GM-CSFS IN AMELIORATING TOXICITY IN AN INTENSIVE TREATMENT PROTOCOL FOR ADVANCED, DIFFUSE B-CELL NHLS, PREDOMINANTLY SMALL NONCLEAVED CELL LYMPHOMAS

      Blood
    28. RAO CR; GUTIERREZ MI; HUSSAIN A; MAGRATH I; BHATIA K
      CONSTITUTIVE EXPRESSION OF FAS-LIGAND IN B-CELL LYMPHOMAS

      Blood
    29. JUDDE JG; SPANGLER G; MAGRATH I; BHATIA K
      USE OF EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-1 IN TARGETED THERAPY OF EBV-ASSOCIATED NEOPLASIA

      Human gene therapy
    30. KHALED HM; ELMAWLA NG; ELSAID A; HAMZA MR; GAAFAR R; ELATTAR I; ABURABIA A; MAGRATH I
      COMBINATION CHEMOTHERAPY FOR ADVANCED BILHARZIAL BLADDER-CARCINOMA

      Annals of oncology
    31. MAGRATH I; ADDE M; SHAD A; VENZON D; SEIBEL N; GOOTENBERG J; NEELY J; ARNDT C; NIEDER M; JAFFE E; WITTES RA; HORAK ID
      ADULTS AND CHILDREN WITH SMALL NON-CLEAVED-CELL LYMPHOMA HAVE A SIMILAR EXCELLENT OUTCOME WHEN TREATED WITH THE SAME CHEMOTHERAPY REGIMEN

      Journal of clinical oncology
    32. KINGMA DW; SHAD A; TSOKOS M; FEST T; OTSUKI T; FREKKO K; WERNER E; WERNER A; MAGRATH I; RAFFELD M; JAFFE ES
      EPSTEIN-BARR-VIRUS (EBV)-ASSOCIATED SMOOTH-MUSCLE TUMOR ARISING IN A POSTTRANSPLANT PATIENT TREATED SUCCESSFULLY FOR 2 PT-EBV-ASSOCIATED LARGE-CELL LYMPHOMAS - CASE-REPORT

      The American journal of surgical pathology
    33. GUTIERREZ MI; RAJ A; SPANGLER G; GUERRERO I; JUDDE JG; MAGRATH I; BHATIA K
      SEQUENCE VARIATIONS IN EBNA-1 SPECIFIC FOR B-CELL OR T-CELL LYMPHOMASMAY UNDERLIE THE PATHOGENETIC ROLE OF EBV IN LYMPHOMAGENESIS

      Blood
    34. KURKURE P; PAI S; VAIDYA S; KAPOOR G; NAIR C; GOPAL R; SAIKIA T; PARIKH P; PAI V; MAGRATH I; ADVANI S
      IMPACT OF IMPROVED SUPPORTIVE CARE ON TREATMENT OUTCOME IN ACUTE LYMPHOBLASTIC-LEUKEMIA - AN INDIAN EXPERIENCE

      European journal of cancer
    35. HAMDY N; BHATIA K; SHAKER H; KAMEL A; ELMAWLA NG; ABOUENEIN M; YASSIN D; ELSHARKAWY N; MAGRATH I
      MOLECULAR EPIDEMIOLOGY OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN EGYPT

      Leukemia
    36. MAGRATH I
      BONE-MARROW TRANSPLANTATION

      Lancet
    37. MAGRATH I
      BONE-MARROW TRANSPLANTATION FOR LEUKEMIA - A LAME STALKING HORSE FOR USE OF HIGH-TECHNOLOGY MEDICAL-CARE

      Lancet
    38. BHATIA K; FAN SJ; SPANGLER G; WEINTRAUB M; OCONNOR PM; JUDDE JG; MAGRATH I
      A MUTANT P21 CYCLIN-DEPENDENT KINASE INHIBITOR ISOLATED FROM A BURKITTS-LYMPHOMA

      Cancer research
    39. ANWAR N; KINGMA DW; BLOCH AR; MOURAD M; RAFFELD M; FRANKLIN J; MAGRATH I; ELBOLKAINY N; JAFFE ES
      THE INVESTIGATION OF EPSTEIN-BARR VIRAL SEQUENCES IN 41 CASES OF BURKITTS-LYMPHOMA FROM EGYPT - EPIDEMIOLOGIC CORRELATIONS

      Cancer
    40. NARESH K; BHATIA K; VENKATESH H; SOMAN C; PAI S; ADVANI S; ADDE M; MAGRATH I
      THE MAJORITY OF PRIMARY LYMPHOBLASTIC LYMPHOMAS EXPRESS P53

      Blood
    41. VENKATESH C; BHATIA K; LOPEZCORELLA E; MESA C; RIVERALUNA R; OCONNOR G; MAGRATH I
      P53 EXPRESSION IN CHILDHOOD NON-HODGKINS-LYMPHOMA IN MEXICO IS MORE FREQUENT IN B-CELL NONLYMPHOBLASTIC LYMPHOMAS THAN IN LYMPHOBLASTIC LYMPHOMAS

      Blood
    42. GUTIERREZ MI; BHATIA K; DIEZ B; MURIEL FS; EPELMAN S; DEANDREAS ML; HUPPI K; MAGRATH I
      PROGNOSTIC-SIGNIFICANCE OF P53 MUTATIONS IN SMALL NON-CLEAVED CELL LYMPHOMAS

      International journal of oncology
    43. BHATIA K; SPANGLER G; HUPPI K; SIWARSKI D; MAGRATH I
      LOSS OF WILD-TYPE C-MYC IN BURKITTS LYMPHOMAS

      Journal of cellular biochemistry
    44. JAIN VK; SEEM N; GESELOVITZ D; NECKERS D; MAGRATH I
      INHIBITION OF IMMUNOGLOBULIN HEAVY-CHAIN (MU)-ENHANCER ACTIVITY BY A DNA OLIGOMER DIRECTED AT THE (MU)E4-MOTIF INHIBITS C-MYC TRANSCRIPTIONIN BURKITTS-LYMPHOMA

      Experimental hematology
    45. FAN SJ; ELDEIRY WS; BAE I; FREEMAN J; JONDLE D; BHATIA K; FORNACE AJ; MAGRATH I; KOHN KW; OCONNOR PM
      P53 GENE-MUTATIONS ARE ASSOCIATED WITH DECREASED SENSITIVITY OF HUMANLYMPHOMA-CELLS TO DNA-DAMAGING AGENTS

      Cancer research
    46. WEINTRAUB M; ADDE M; SHAD A; HORAK I; SEIBEL N; NEELY J; MAGRATH I
      PROFOUND PERIPHERAL NEUROPATHY ASSOCIATED WITH THE ADMINISTRATION OF COLONY-STIMULATING FACTORS

      Blood
    47. GREVER MR; BHATIA K; GIAVAZZI R; HOLLINGSHEAD M; MAGRATH I; MALSPEIS L; MAYO J; SHORES R
      EXPERIMENTAL THERAPEUTIC AGENTS IN AN AIDS-RELATED SCID MOUSE MODEL

      Blood
    48. FRANKLIN JL; NARESH KN; CACERES E; BHATIA K; OCONOR G; MAGRATH I
      P53 EXPRESSION, BCL-2 EXPRESSION AND EBV ASSOCIATION IN PERUVIAN NASAL LYMPHOMAS

      Blood
    49. BHATIA K; HUPPI K; SPANGLER G; SIWARSKI D; IYER R; MAGRATH I
      POINT MUTATIONS IN THE C-MYC TRANSACTIVATION DOMAIN ARE COMMON IN BURKITTS-LYMPHOMA AND MOUSE PLASMACYTOMAS

      Nature genetics
    50. BHATIA K; GOLDSCHMIDTS W; GUTIERREZ M; GAIDANO G; DALLAFAVERA R; MAGRATH I
      HEMIZYGOSITY OR HOMOZYGOSITY - A REQUIREMENT FOR SOME BUT NOT OTHER P53 MUTANT PROTEINS TO ACCUMULATE AND EXERT A PATHOGENETIC EFFECT

      The FASEB journal
    51. OCONNOR PM; JACKMAN J; JONDLE D; BHATIA K; MAGRATH I; KOHN KW
      ROLE OF THE P53 TUMOR-SUPPRESSOR GENE IN CELL-CYCLE ARREST AND RADIOSENSITIVITY OF BURKITTS-LYMPHOMA CELL-LINES

      Cancer research
    52. SHAD A; ADDE M; MAGRATH I
      RESULTS OF NCI PROTOCOL 77-04 FOR TREATMENT OF LYMPHOBLASTIC LYMPHOMAIN CHILDREN

      Blood
    53. SHAD A; BHATIA K; HAMDY N; MUELLER B; PIZZO P; PENG JW; KNUTSEN T; JAFFE E; MAGRATH I
      MOLECULAR CHARACTERIZATION OF PEDIATRIC HIV-ASSOCIATED NON-HODGKINS-LYMPHOMAS

      Blood
    54. MAGRATH I; LITVAK J
      CANCER IN DEVELOPING-COUNTRIES - OPPORTUNITY AND CHALLENGE

      Journal of the National Cancer Institute


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/01/21 alle ore 11:22:55